STNE StoneCo

StoneCo Ltd. Announces New Independent Member of Board of Directors and Audit Committee

StoneCo Ltd. Announces New Independent Member of Board of Directors and Audit Committee

SÃO PAULO, Brazil, July 05, 2019 (GLOBE NEWSWIRE) -- StoneCo Ltd. (NASDAQ: STNE) (“Stone”) announced that pursuant to written resolutions of its Board of Directors dated June 27, 2019, Mr. Silvio José Morais was appointed to the Board of Directors, effective immediately, and at the same meeting, elected to the Audit Committee. Mr. Morais is independent under the applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) and the listing standards of the Nasdaq Stock Market.

Prior to joining the board of directors of Stone, Mr. Morais served as Controller at Ambev S.A. from 1998 to 2019, where he was responsible for the Financial Reporting, Internal Controls, Pension Plan and Direct Tax functions. Between 1988 and 1998, he held various other positions at Ambev S.A. Between 2008 and 2019 he also served as an officer at IAPP – Instituto Ambev de Previdencia Privada, and has been a board member since March 2019. Mr. Morais is also a board member, a position he has held since 2017, and an executive director, a position he has held since 2018, of Fundação Antonio e Helena Zerrenner. Since May 2019 he is board member at Falconi Participações S.A., the entity which controls Falconi Consultoria, a consultant firm specialized in management. Additionally, between May 2018 and April 2019 he served as an alternate member of ITAUSA’s board of directors. Mr. Morais received a degree in business management at FACE-PR, a postgraduate degree in Finance at FAE Business School, and an MBA in Controllership from Fipecafi – USP.

With Mr. Morais’s appointment, Stone’s current Board members are Mr. André Street, Mr. Eduardo Cunha Monnerat Solon de Pontes and Mr. Thomas A. Patterson and the independent members Mr. Ali Mazanderani, Mr. Roberto Moses Thompson Motta and Mr. Morais (“Independent Members”). The Audit Committee consists of three members, namely the Independent Members, who satisfy the criteria of audit committee financial expert as set forth under the applicable rules of the SEC.

About Stone:

Stone is a leading provider of financial technology solutions that empower merchants to conduct commerce seamlessly across multiple channels and help them grow their business over time through technology.

Contact:

ICR, Inc.



Source: StoneCo Ltd.

EN
05/07/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on StoneCo

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Soomit Datta
  • Soomit Datta

STNE US (Neutral, TP: R$15, +40%) Q3 24 - Promising pricing; PIX and r...

StoneCo reported Q3s after close. Underlying TPV growth on MSMB including PIX remained at a healthy 20% y/y, slowing a touch from 25% in Q2, whilst profitability was good with numbers coming in ahead at PBT (6%) – supported partly by unwinding of credit provisions.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch